Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

British Journal of Cancer

Volumn 80, Issue 1-2, 1999, Pages 309-313

  Tsurusaki, T ^a   Kanda, S ^a   Sakai, H ^a   Kanetake, H ^a   Saito, Y ^a   Alitalo, K ^b   Koji, T ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Lymph node metastasis; Prostatic carcinoma; Vascular endothelial growth factor C; VEGF receptor 3

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; STROMA;

ADENOCARCINOMA; ENDOTHELIAL GROWTH FACTORS; HUMANS; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 0032923081     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690356     Document Type: Article

References (23)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K and Stacker SA (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor-2 (Flk1) and VEGF receptor-3 (Flt-4). Proc Natl Acad Sci USA 95: 548-553
2. Adams JC (1981) Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29: 775
3. Barleon B, Sozzani S, Zhou D, Weich H, Mantovani A and Marmé D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343
4. Clauss M, Weich H, Breier G, Knies U, Rock W, Waltenberger J and Risau W (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 211: 17629-17634
5. Dvorak HF, Brown LF, Detmar M and Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am J Pathol 146: 1029-1039
6. Epstein JI, Partin AW, Sauvageot J and Walsh PC (1996) Prediction of progression following radical prostatectomy: a multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 20: 286-292
7. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocrine Rev 18: 4-25
8. Folkman J and Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934
9. Fong G-H, Rossant J, Gertenstein M and Breitman M (1995) Role of Flt-1 receptor tyrosine kinase in regulation of assembly of vascular endothelium. Nature 376: 66-67
10. Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In Urologic Pathology: Prostate, Tannenbaum M (ed), pp. 171-198. Lea & Febiger, Philadelphia
11. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK and Alitaro K (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425
12. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298
13. Jussila L, Valtola R, Partanen TA, Salven P, Heikkilä P, Matikainen M-T, Renkonen R. Kaipainen A, Detmar M, Tschachler E, Alitalo R and Alitalo K (1998) Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58: 1599-1604
14. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G-H, Dumont D, Beitman M and Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570
15. Koji T and Nakane PK (1996) Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry. J Electron Micros 45: 119-127
16. Oh S-J, Jeltsch M, Birkenhäger R, McCarthy JEG, Weich HA, Christ B, Alitaro K and Wilting J (1997) VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96-109
17. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R and Alitalo K (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52: 5738-5743
18. Shalabi F, Rossant J, Yamaguchi TP, Gertenstein M, Wu X-F, Breitman ML and Schuh AC (1995) Failure of blood island formation and vasculogenesis in Flk-1 dificient mice. Nature 376: 62-66
19. Slack NH, Lane WW, Priore RL and Murphy GP (1986) Prostatic cancer treated at a categorical center, 1980-1983. Urology 27: 205-213
20. Steiner MS (1993) Role of peptide growth factors in the prostate: a review. Urology 42: 99-110
21. Tsurusaki T. Koji T, Sakai H, Kanetake H, Nakane PK and Saito Y (1998) Cellular expression of beta-microseminoprotein (β-MSP) mRNA and its protein in untreated prostate cancer. Prostate 35: 109-116
22. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M and Heldin C-H (1994) Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988-26995
23. Yoshii A, Koji T, Ohsawa N and Nakane PK (1995) In situ localization of ribosomal RNAs in a reliable reference for hybridizable RNA in tissue sections. J Histochem Cytochem 43: 321-327